New findings on the most common form of childhood cancer. Of all the drugs being discussed at this year’s meeting of the American Society of Hematology, one caught my attention. The new agent, a monoclonal.
Salon owner shaves head after daughter raises more than $50,000 for leukemia research
Annabel named her grant in honor of 12-year-old William Sweger. “William has acute lymphoblastic leukemia,” said Derek Nesbit, Sweger’s dad. “I’m just tired all the time. You feel like you have the flu all the time,” Sweger said. “You’re
CAR-T drugs worth up to $649K in childhood leukemia, says U.K. report
Health authorities in Britain ran cost-effectiveness numbers on pioneering CAR-T therapies that might be used to treat acute lymphoblastic leukemia for young patients with acute lymphoblastic leukemia (ALL). That doesn't mean Novartis, Kite and other
Expert Discusses Success of Blinatumomab in ALL
The anti-CD19 agent blinatumomab (Blincyto) received an accelerated approval from the FDA in December 2014 as a treatment for patients with Philadelphia chromosome-negative (Ph-) relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Dancing back to recovery
Caroline Laughorn loves to dance. “It takes me away from all the other stuff,” she said in a recent interview. “The other stuff” is acute lymphoblastic leukemia, a disease with which Caroline was diagnosed when she was only 8-years-old and in the